Idexx Laboratories Inc
$563.39
USD
Last updated on --.
24h volume657.12K
24h highest574.00 USD
24h lowest562.95 USD
24h Price movement-0.02%
IDXX recent prices
24 Hours
-0.02%-$0.14
30 days
-0.72%-$4.070
60 days
-0.22%-$1.270
90 days
-11.51%-$73.31
Key data
Previous close563.53 USD
Market cap43.46B USD
Volume657.12K
P/E ratio39.680000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)13.8800 USD
Net income (FY)1.10B USD
Revenue (FY)4.45B USD
Last report dateMay 5, 2026
About Idexx Laboratories Inc
HeadquartersWESTBROOK
Employees (FY)11.00K
Revenue per employee (FY)404.19K USD
Net income per employee (FY)99.57K USD
Listed onNasdaq
IDXX conversion tables
 |  |
|---|---|
| 0.5 IDXX | 281.69 USD |
| 1 IDXX | 563.39 USD |
| 5 IDXX | 2,816.95 USD |
| 10 IDXX | 5,633.9 USD |
| |
|---|---|
| 0.5 USD | 0.00088748 IDXX |
| 1 USD | 0.001775 IDXX |
| 5 USD | 0.0088748 IDXX |
| 10 USD | 0.01775 IDXX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
IDXX is trading at $563.39, -0.02% over the last 24 hours. Track live moves on the price chart at the top of this page.
The IDXX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. IDXX is currently trading at $563.39, -0.02% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on IDXX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. IDXX's P/E ratio is currently 39.680000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from IDXX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against IDXX's historical range and other companies in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.
Idexx Laboratories Inc's market cap is currently 43.46B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume657.12K
24h highest574.00 USD
24h lowest562.95 USD
24h Price movement-0.02%
Start trade with IDXX Perpetual
Sign up to trade